BILL NUMBER: SB 294 AMENDED
BILL TEXT
AMENDED IN ASSEMBLY JUNE 24, 2013
AMENDED IN SENATE MAY 28, 2013
INTRODUCED BY Senator Emmerson
FEBRUARY 15, 2013
An act to amend the heading of Article 7.5 (commencing with
Section 4127) of Chapter 9 of Division 2 of, and to amend, repeal,
and add Sections 4127, 4127.1, 4127.2, and 4400 of, the Business and
Professions Code, relating to pharmacy.
LEGISLATIVE COUNSEL'S DIGEST
SB 294, as amended, Emmerson. Sterile drug products.
(1) The Pharmacy Law provides for the licensure and regulation of
pharmacists and pharmacy corporations in this state by the California
State Board of Pharmacy. Existing law requires the board to adopt
regulations establishing standards for compounding injectable sterile
drug products in a pharmacy. Existing law requires pharmacies to
obtain a license from the board, subject to annual renewal, in order
to compound injectable sterile drug products. A similar licensing
requirement applies to nonresident pharmacies compounding injectable
sterile drug products for shipment into California. A violation of
the Pharmacy Law is a crime.
This bill , commencing July 1, 2014, would expand these
provisions to prohibit a pharmacy from compounding or dispensing,
and a nonresident pharmacy from compounding for shipment into this
state, sterile drug products for injection, administration into the
eye, or inhalation, unless the pharmacy has obtained a sterile
compounding pharmacy license from the board. The bill ,
commencing July 1, 2014, would specify requirements for the
board for the issuance or renewal of a license, and requirements for
the pharmacy as a licensee. The bill would require the board to
adopt regulations to implement these provisions, as specified.
By adding additional requirements to the Pharmacy Law concerning
sterile drug products, the violation of which is a crime, the bill
would impose a state-mandated local program.
(2) Existing law specifies the fee for issuance or renewal of a
nongovernmental license to compound sterile drug products.
This bill , commencing July 1, 2014, would
require the board to establish, by regulation,
establish the fee for the issuance or renewal of a nonresident
sterile compounding pharmacy license, in an amount not to
exceed the reasonable regulatory costs of issuing and renewing the
license, or $2,800, whichever is less. The bill would also require
the nonresident sterile compounding pharmacy to reimburse the board
for all costs incurred by the board in conducting an inspection of
the pharmacy at least once annually, including, but not limited to,
travel expenses, meals, lodging, and other actual and necessary costs
incurred by the board in connection with the inspection. The failure
to reimburse the board for these costs within 30 days of the
inspection would result in the suspension of the nonresident sterile
compounding pharmacy license license in the amount of
$780 and would require the applicant to deposit a
reasonable amount, as determined by the board, necessary to cover the
board's estimated cost of performing an inspection of the
nonresident pharmacy location, as specified .
(3) The provisions of the bill would become operative on July 1,
2014.
(4)
(3) The California Constitution requires the state to
reimburse local agencies and school districts for certain costs
mandated by the state. Statutory provisions establish procedures for
making that reimbursement.
This bill would provide that no reimbursement is required by this
act for a specified reason.
Vote: majority. Appropriation: no. Fiscal committee: yes.
State-mandated local program: yes.
THE PEOPLE OF THE STATE OF CALIFORNIA DO ENACT AS FOLLOWS:
SECTION 1. The heading of Article 7.5 (commencing with Section
4127) of Chapter 9 of Division 2 of the Business and Professions Code
is amended to read:
Article 7.5. Sterile Drug Products
SEC. 2. Section 4127 of the Business and Professions Code is
amended to read:
4127. (a) The board shall adopt regulations establishing
standards for compounding injectable sterile drug products in a
pharmacy.
(b) The board shall adopt emergency regulations in accordance with
the Administrative Procedure Act (Chapter 3.5 (commencing with
Section 11340) of Part 1 of Division 3 of Title 2 of the Government
Code) to establish policies, guidelines, and procedures to initially
implement the provisions of this article that become operative on
July 1, 2014, including, but not limited to, building standards
adopted pursuant to Part 2.5 (commencing with Section 18901) of
Division 13 of the Health and Safety Code. The initial adoption,
amendment, or repeal of a regulation authorized by this section is
deemed to address an emergency for purposes of Sections 11346.1 and
11346.6 of the Government Code, and the board is hereby exempted for
that purpose from the requirements of subdivision (b) of Section
11346.1 of the Government Code. After the initial adoption,
amendment, or repeal of an emergency regulation pursuant to this
section, the board shall not request approval from the Office of
Administrative Law to readopt the regulation as an emergency
regulation pursuant to Section 11346.1 of the Government Code.
(b)
(c) This section shall become inoperative on July 1,
2014, and, as of January 1, 2015, is repealed, unless a later enacted
statute, that becomes operative on or before January 1, 2015,
deletes or extends the dates on which it becomes inoperative and is
repealed.
SEC. 3. Section 4127 is added to the Business and Professions
Code, to read:
4127. (a) A pharmacy that compounds sterile drug products for
injection, administration into the eye, or inhalation shall possess a
sterile compounding pharmacy license as provided in this article
before dispensing the compounded medication .
(b) The board shall adopt regulations in accordance with the
Administrative Procedure Act (Chapter 3.5 (commencing with Section
11340) of Part 1 of Division 3 of Title 2 of the Government Code) to
establish policies, guidelines, and procedures to implement this
article, including, but not limited to, building standards adopted
pursuant to Part 2.5 (commencing with Section 18901) of Division 13
of the Health and Safety Code.
(b)
( c) This section shall become operative on
July 1, 2014.
SEC. 4. Section 4127.1 of the Business and Professions Code is
amended to read:
4127.1. (a) A pharmacy shall not compound injectable sterile drug
products in this state unless the pharmacy has obtained a license
from the board pursuant to this section. The license shall be renewed
annually and is not transferable.
(b) A license to compound injectable sterile drug products may
only be issued for a location that is licensed as a pharmacy.
Furthermore, the license to compound injectable sterile drug products
may only be issued to the owner of the pharmacy license at that
location. A license to compound injectable sterile drug products may
not be issued until the location is inspected by the board and found
in compliance with this article and regulations adopted by the board.
(c) A license to compound injectable sterile drug products may not
be renewed until the location has been inspected by the board and
found to be in compliance with this article and regulations adopted
by the board.
(d) Pharmacies operated by entities that are licensed by either
the board or the State Department of Public Health and that have
current accreditation from the Joint Commission on Accreditation of
Healthcare Organizations, or other private accreditation agencies
approved by the board, are exempt from the requirement to obtain a
license pursuant to this section.
(e) The reconstitution of a sterile powder shall not require a
license pursuant to this section if both of the following are met:
(1) The sterile powder was obtained from a manufacturer.
(2) The drug is reconstituted for administration to patients by a
health care professional licensed to administer drugs by injection
pursuant to this division.
(f) This section shall become inoperative on July 1, 2014, and, as
of January 1, 2015, is repealed, unless a later enacted statute,
that becomes operative on or before January 1, 2015, deletes or
extends the dates on which it becomes inoperative and is repealed.
SEC. 5. Section 4127.1 is added to the Business and Professions
Code, to read:
4127.1. (a) A pharmacy shall not compound sterile drug products
unless the pharmacy has obtained a sterile compounding pharmacy
license from the board pursuant to this section. The license shall be
renewed annually and is not transferable.
(b) A license to compound sterile drug products shall be issued
only to a location that is licensed as a pharmacy.
Furthermore, the license to compound sterile drug products
pharmacy and shall be issued only to the owner of the
pharmacy licensed at that location. A
(c) A license to compound sterile
drug products shall not be issued or renewed until the
location is inspected by the board and found in compliance with this
article and regulations adopted by the board.
(c)
( d) A license to compound sterile drug
products shall not be issued or renewed until the board does all of
the following:
(1) Performs an onsite inspection of the premises, and any
deficiencies noted are corrected.
(2)
( 1) Reviews a current copy of the pharmacy'
s policies and procedures for sterile compounding.
(3)
( 2) Reviews the pharmacy's completed
self-assessment form required by Section 1735.2 of Title 16 of the
California Code of Regulations.
(4)
( 3) Is provided with copies of all
inspection reports conducted of the pharmacy's premises, and any
reports from a private accrediting agency, conducted in the prior 12
months documenting the pharmacy's operations.
(5)
( 4) Receives a list of all sterile
medications compounded by the pharmacy since the last license
renewal.
(d)
( e) A pharmacy licensed pursuant to this
section shall do all of the following:
(1) Provide to the board a copy of any disciplinary or other
action taken by another state within 10 days of the action.
(2) Notify the board within 10 days of the suspension of any
accreditation held by the pharmacy.
(3) Provide to the board, within 24 12
hours, any recall notice issued by the pharmacy for sterile
drug products it has compounded.
(e)
( f) Adverse effects reported or potentially
attributable to a pharmacy's sterile drug product shall be
immediately reported to the board and the MedWatch program of the
federal Food and Drug Administration.
(f)
( g) The reconstitution of a sterile powder
shall not require a license pursuant to this section if both of the
following requirements are met:
(1) The sterile powder was obtained from a manufacturer.
(2) The drug is reconstituted for administration to patients by a
health care professional licensed to administer drugs by injection
pursuant to this division.
(g)
( h) This section shall become operative on
July 1, 2014.
SEC. 6. Section 4127.2 of the Business and Professions Code is
amended to read:
4127.2. (a) A nonresident pharmacy shall not compound injectable
sterile drug products for shipment into the State of California
without a license issued by the board pursuant to this section. The
license shall be renewed annually and shall not be transferable.
(b) A license to compound injectable sterile drug products may
only be issued for a location that is licensed as a nonresident
pharmacy. Furthermore, the license to compound injectable sterile
drug products may only be issued to the owner of the nonresident
pharmacy license at that location. A license to compound injectable
sterile drug products may not be issued or renewed until the board
receives the following from the nonresident pharmacy:
(1) A copy of an inspection report issued by the pharmacy's
licensing agency, or a report from a private accrediting agency
approved by the board, in the prior 12 months documenting the
pharmacy's compliance with board regulations regarding the
compounding of injectable sterile drug products.
(2) A copy of the nonresident pharmacy's proposed policies and
procedures for sterile compounding.
(c) Nonresident pharmacies operated by entities that are licensed
as a hospital, home health agency, or a skilled nursing facility and
have current accreditation from the Joint Commission on Accreditation
of Healthcare Organizations, or other private accreditation agencies
approved by the board, are exempt from the requirement to obtain a
license pursuant to this section.
(d) This section shall become inoperative on July 1, 2014, and, as
of January 1, 2015, is repealed, unless a later enacted statute,
that becomes operative on or before January 1, 2015, deletes or
extends the dates on which it becomes inoperative and is repealed.
SEC. 7. Section 4127.2 is added to the Business and Professions
Code, to read:
4127.2. (a) A nonresident pharmacy shall not compound sterile
drug products for shipment into this state without a sterile
compounding pharmacy license issued by the board pursuant to this
section. The license shall be renewed annually and shall not be
transferable.
(b) A license to compound sterile drug products shall be issued
only to a location that is licensed as a nonresident
pharmacy. Furthermore, the license to compound sterile drug products
pharmacy and shall be issued only to the owner
of the nonresident pharmacy licensed at that location. A
(c) A license to compound sterile
drug products shall not be issued or renewed until the
location is inspected by the board and found in compliance with this
article and any regulations adopted by the board. The
nonresident pharmacy shall reimburse the board for all actual and
necessary costs incurred by the board in conducting an
inspection of the pharmacy at least once annually pursuant to
subdivision (v) of Section 4400.
(c)
( d) A license to compound sterile drug
products shall not be issued or renewed until the board does all of
the following:
(1) Performs an onsite inspection of the premises, and any
deficiencies noted are corrected. The nonresident pharmacy shall be
responsible for payment of reasonable travel expenses incurred by the
board in connection with inspecting the pharmacy at least once
annually pursuant to subdivision (v) of Section 4400.
(2)
( 1) Reviews a current copy of the
nonresident pharmacy's policies and procedures for sterile
compounding.
(3)
( 2) Reviews the pharmacy's completed
self-assessment form required by Section 1735.2 of Title 16 of the
California Code of Regulations.
(4)
( 3) Is provided with copies of all
inspection reports conducted of the nonresident pharmacy's premises,
and any reports from a private accrediting agency, conducted in the
prior 12 months documenting the nonresident pharmacy's operations.
(5)
( 4) Receives a list of all sterile drug
products compounded by the pharmacy within the prior 12 months.
(d)
( e) A pharmacy licensed pursuant to this
section shall do all of the following:
(1) Provide to the board a copy of any disciplinary or other
action taken by its state of residence or another state within 10
days of the action.
(2) Notify the board within 10 days of the suspension of any
accreditation held by the pharmacy.
(3) Provide to the board, within 24 12
hours, any recall notice issued by the pharmacy for sterile
drug products it has compounded that have been shipped into, or
dispensed in, California.
(4) Advise the board of any complaint it receives from a provider,
pharmacy, or patient in California.
(e)
( f) Adverse effects reported or potentially
attributable to a nonresident pharmacy's sterile compounded drug
product shall be immediately reported to the board and the MedWatch
program of the federal Food and Drug Administration.
(f)
( g) This section shall become operative on
July 1, 2014.
SEC. 8. Section 4400 of the Business and Professions Code is
amended to read:
4400. The amount of fees and penalties prescribed by this
chapter, except as otherwise provided, is that fixed by the board
according to the following schedule:
(a) The fee for a nongovernmental pharmacy license shall be four
hundred dollars ($400) and may be increased to five hundred twenty
dollars ($520). The fee for the issuance of a temporary
nongovernmental pharmacy permit shall be two hundred fifty dollars
($250) and may be increased to three hundred twenty-five dollars
($325).
(b) The fee for a nongovernmental pharmacy license annual renewal
shall be two hundred fifty dollars ($250) and may be increased to
three hundred twenty-five dollars ($325).
(c) The fee for the pharmacist application and examination shall
be two hundred dollars ($200) and may be increased to two hundred
sixty dollars ($260).
(d) The fee for regrading an examination shall be ninety dollars
($90) and may be increased to one hundred fifteen dollars ($115). If
an error in grading is found and the applicant passes the
examination, the regrading fee shall be refunded.
(e) The fee for a pharmacist license and biennial renewal shall be
one hundred fifty dollars ($150) and may be increased to one hundred
ninety-five dollars ($195).
(f) The fee for a nongovernmental wholesaler license and annual
renewal shall be six hundred dollars ($600), and may be increased to
seven hundred eighty dollars ($780). The application fee for any
additional location after licensure of the first 20 locations shall
be two hundred twenty-five dollars ($225) and may be increased to
three hundred dollars ($300). A temporary license fee shall be five
hundred fifty dollars ($550) and may be increased to seven hundred
fifteen dollars ($715).
(g) The fee for a hypodermic license and renewal shall be one
hundred twenty-five dollars ($125) and may be increased to one
hundred sixty-five dollars ($165).
(h) (1) The fee for application, investigation, and issuance of
license as a designated representative pursuant to Section 4053 shall
be two hundred fifty-five dollars ($255) and may be increased to
three hundred thirty dollars ($330).
(2) The fee for the annual renewal of a license as a designated
representative shall be one hundred fifty dollars ($150) and may be
increased to one hundred ninety-five dollars ($195).
(i) (1) The fee for the application, investigation, and issuance
of a license as a designated representative for a veterinary
food-animal drug retailer pursuant to Section 4053 shall be two
hundred fifty-five dollars ($255) and may be increased to three
hundred thirty dollars ($330).
(2) The fee for the annual renewal of a license as a designated
representative for a veterinary food-animal drug retailer shall be
one hundred fifty dollars ($150) and may be increased to one hundred
ninety-five dollars ($195).
(j) (1) The application fee for a nonresident wholesaler's license
issued pursuant to Section 4161 shall be six hundred dollars ($600)
and may be increased to seven hundred eighty dollars ($780).
(2) For nonresident wholesalers who have 21 or more facilities
operating nationwide the application fees for the first 20 locations
shall be six hundred dollars ($600) and may be increased to seven
hundred eighty dollars ($780). The application fee for any additional
location after licensure of the first 20 locations shall be two
hundred twenty-five dollars ($225) and may be increased to three
hundred dollars ($300). A temporary license fee shall be five hundred
fifty dollars ($550) and may be increased to seven hundred fifteen
dollars ($715).
(3) The annual renewal fee for a nonresident wholesaler's license
issued pursuant to Section 4161 shall be six hundred dollars ($600)
and may be increased to seven hundred eighty dollars ($780).
(k) The fee for evaluation of continuing education courses for
accreditation shall be set by the board at an amount not to exceed
forty dollars ($40) per course hour.
(l) The fee for an intern pharmacist license shall be ninety
dollars ($90) and may be increased to one hundred fifteen dollars
($115). The fee for transfer of intern hours or verification of
licensure to another state shall be twenty-five dollars ($25) and may
be increased to thirty dollars ($30).
(m) The board may waive or refund the additional fee for the
issuance of a license where the license is issued less than 45 days
before the next regular renewal date.
(n) The fee for the reissuance of any license, or renewal thereof,
that has been lost or destroyed or reissued due to a name change
shall be thirty-five dollars ($35) and may be increased to forty-five
dollars ($45).
(o) The fee for the reissuance of any license, or renewal thereof,
that must be reissued because of a change in the information, shall
be one hundred dollars ($100) and may be increased to one hundred
thirty dollars ($130).
(p) It is the intent of the Legislature that, in setting fees
pursuant to this section, the board shall seek to maintain a reserve
in the Pharmacy Board Contingent Fund equal to approximately one year'
s operating expenditures.
(q) The fee for any applicant for a nongovernmental clinic license
shall be four hundred dollars ($400) and may be increased to five
hundred twenty dollars ($520) for each license. The annual fee for
renewal of the license shall be two hundred fifty dollars ($250) and
may be increased to three hundred twenty-five dollars ($325) for each
license.
(r) The fee for the issuance of a pharmacy technician license
shall be eighty dollars ($80) and may be increased to one hundred
five dollars ($105). The fee for renewal of a pharmacy technician
license shall be one hundred dollars ($100) and may be increased to
one hundred thirty dollars ($130).
(s) The fee for a veterinary food-animal drug retailer license
shall be four hundred five dollars ($405) and may be increased to
four hundred twenty-five dollars ($425). The annual renewal fee for a
veterinary food-animal drug retailer license shall be two hundred
fifty dollars ($250) and may be increased to three hundred
twenty-five dollars ($325).
(t) The fee for issuance of a retired license pursuant to Section
4200.5 shall be thirty-five dollars ($35) and may be increased to
forty-five dollars ($45).
(u) The fee for issuance or renewal of a nongovernmental license
to compound sterile drug products shall be six hundred dollars ($600)
and may be increased to seven hundred eighty dollars ($780). The fee
for a temporary license shall be five hundred fifty dollars ($550)
and may be increased to seven hundred fifteen dollars ($715).
(v) This section shall become inoperative on July 1, 2014, and, as
of January 1, 2015, is repealed, unless a later enacted statute,
that becomes operative on or before January 1, 2015, deletes or
extends the dates on which it becomes inoperative and is repealed.
SEC. 9. Section 4400 is added to the Business and Professions
Code, to read:
4400. The amount of fees and penalties prescribed by this
chapter, except as otherwise provided, is that fixed by the board
according to the following schedule:
(a) The fee for a nongovernmental pharmacy license shall be four
hundred dollars ($400) and may be increased to five hundred twenty
dollars ($520). The fee for the issuance of a temporary
nongovernmental pharmacy permit shall be two hundred fifty dollars
($250) and may be increased to three hundred twenty-five dollars
($325).
(b) The fee for a nongovernmental pharmacy license annual renewal
shall be two hundred fifty dollars ($250) and may be increased to
three hundred twenty-five dollars ($325).
(c) The fee for the pharmacist application and examination shall
be two hundred dollars ($200) and may be increased to two hundred
sixty dollars ($260).
(d) The fee for regrading an examination shall be ninety dollars
($90) and may be increased to one hundred fifteen dollars ($115). If
an error in grading is found and the applicant passes the
examination, the regrading fee shall be refunded.
(e) The fee for a pharmacist license and biennial renewal shall be
one hundred fifty dollars ($150) and may be increased to one hundred
ninety-five dollars ($195).
(f) The fee for a nongovernmental wholesaler license and annual
renewal shall be six hundred dollars ($600), and may be increased to
seven hundred eighty dollars ($780). The application fee for any
additional location after licensure of the first 20 locations shall
be two hundred twenty-five dollars ($225) and may be increased to
three hundred dollars ($300). A temporary license fee shall be five
hundred fifty dollars ($550) and may be increased to seven hundred
fifteen dollars ($715).
(g) The fee for a hypodermic license and renewal shall be one
hundred twenty-five dollars ($125) and may be increased to one
hundred sixty-five dollars ($165).
(h) (1) The fee for application, investigation, and issuance of
license as a designated representative pursuant to Section 4053 shall
be two hundred fifty-five dollars ($255) and may be increased to
three hundred thirty dollars ($330).
(2) The fee for the annual renewal of a license as a designated
representative shall be one hundred fifty dollars ($150) and may be
increased to one hundred ninety-five dollars ($195).
(i) (1) The fee for the application, investigation, and issuance
of a license as a designated representative for a veterinary
food-animal drug retailer pursuant to Section 4053 shall be two
hundred fifty-five dollars ($255) and may be increased to three
hundred thirty dollars ($330).
(2) The fee for the annual renewal of a license as a designated
representative for a veterinary food-animal drug retailer shall be
one hundred fifty dollars ($150) and may be increased to one hundred
ninety-five dollars ($195).
(j) (1) The application fee for a nonresident wholesaler's license
issued pursuant to Section 4161 shall be six hundred dollars ($600)
and may be increased to seven hundred eighty dollars ($780).
(2) For nonresident wholesalers who have 21 or more facilities
operating nationwide the application fees for the first 20 locations
shall be six hundred dollars ($600) and may be increased to seven
hundred eighty dollars ($780). The application fee for any additional
location after licensure of the first 20 locations shall be two
hundred twenty-five dollars ($225) and may be increased to three
hundred dollars ($300). A temporary license fee shall be five hundred
fifty dollars ($550) and may be increased to seven hundred fifteen
dollars ($715).
(3) The annual renewal fee for a nonresident wholesaler's license
issued pursuant to Section 4161 shall be six hundred dollars ($600)
and may be increased to seven hundred eighty dollars ($780).
(k) The fee for evaluation of continuing education courses for
accreditation shall be set by the board at an amount not to exceed
forty dollars ($40) per course hour.
(l) The fee for an intern pharmacist license shall be ninety
dollars ($90) and may be increased to one hundred fifteen dollars
($115). The fee for transfer of intern hours or verification of
licensure to another state shall be twenty-five dollars ($25) and may
be increased to thirty dollars ($30).
(m) The board may waive or refund the additional fee for the
issuance of a license where the license is issued less than 45 days
before the next regular renewal date.
(n) The fee for the reissuance of any license, or renewal thereof,
that has been lost or destroyed or reissued due to a name change
shall be thirty-five dollars ($35) and may be increased to forty-five
dollars ($45).
(o) The fee for the reissuance of any license, or renewal thereof,
that must be reissued because of a change in the information, shall
be one hundred dollars ($100) and may be increased to one hundred
thirty dollars ($130).
(p) It is the intent of the Legislature that, in setting fees
pursuant to this section, the board shall seek to maintain a reserve
in the Pharmacy Board Contingent Fund equal to approximately one year'
s operating expenditures.
(q) The fee for any applicant for a nongovernmental clinic license
shall be four hundred dollars ($400) and may be increased to five
hundred twenty dollars ($520) for each license. The annual fee for
renewal of the license shall be two hundred fifty dollars ($250) and
may be increased to three hundred twenty-five dollars ($325) for each
license.
(r) The fee for the issuance of a pharmacy technician license
shall be eighty dollars ($80) and may be increased to one hundred
five dollars ($105). The fee for renewal of a pharmacy technician
license shall be one hundred dollars ($100) and may be increased to
one hundred thirty dollars ($130).
(s) The fee for a veterinary food-animal drug retailer license
shall be four hundred five dollars ($405) and may be increased to
four hundred twenty-five dollars ($425). The annual renewal fee for a
veterinary food-animal drug retailer license shall be two hundred
fifty dollars ($250) and may be increased to three hundred
twenty-five dollars ($325).
(t) The fee for issuance of a retired license pursuant to Section
4200.5 shall be thirty-five dollars ($35) and may be increased to
forty-five dollars ($45).
(u) The fee for issuance or renewal of a nongovernmental sterile
compounding pharmacy license shall be six hundred dollars ($600) and
may be increased to seven hundred eighty dollars ($780). The fee for
a temporary license shall be five hundred fifty dollars ($550) and
may be increased to seven hundred fifteen dollars ($715).
(v) The board shall establish, by regulation, the
fee for the issuance or renewal of a nonresident
sterile compounding pharmacy license in an amount not to
exceed the reasonable regulatory costs of issuing and renewing the
license, or two thousand eight hundred dollars ($2,800), whichever is
less shall
be seven hundred eighty dollars ($780) . In addition to paying
the license that application fee, the
nonresident sterile compounding pharmacy shall reimburse the
board for all costs incurred by the board in conducting an
inspection of the pharmacy at least once annually, including, but not
limited to, travel expenses, meals, lodging, and other actual and
necessary costs incurred by the board in connection with the
inspection. Failure to reimburse the board for all costs associated
with the annual inspection, as authorized by this subdivision, within
30 days of the inspection shall result in the suspension of the
nonresident sterile compounding pharmacy license
deposit, when submitting the application, a reasonable amount, as
determined by the board, necessary to cover the board's estimated
cost of performing the inspection required by Section 4127.2. If the
required deposit is not submitted with the application, the
application shall be deemed to b e incomplete. If the
actual cost of the inspection exceeds the amount deposited, the board
shall provide to the applicant a written invoice for the remaining
amount and shall not take action on the application until the full
amount has been paid to the board. If the amount deposited exceeds
the amount of actual and necessary costs incurred, the board shall
remit the difference to the applicant .
(w) This section shall become operative on July 1, 2014.
SEC. 10. No reimbursement is required by this act pursuant to
Section 6 of Article XIII B of the California Constitution because
the only costs that may be incurred by a local agency or school
district will be incurred because this act creates a new crime or
infraction, eliminates a crime or infraction, or changes the penalty
for a crime or infraction, within the meaning of Section 17556 of the
Government Code, or changes the definition of a crime within the
meaning of Section 6 of Article XIII B of the California
Constitution.